GSK-3β activation mediates Nogo-66-induced inhibition of neurite outgrowth in N2a cells

The axons of the adult mammalian brain and spinal cord fail to regenerate after injury, and it has been suggested that Nogo-66 could prevent CNS axon repair. However, the mechanism of Nogo-66 inhibiting neurite outgrowth remains unknown. Our previous results indicated that protein kinase B (PKB) is involved in the inhibition of the neurite outgrowth by Nogo-66. Glycogen synthase kinase-3β (GSK-3β) is implicated in many processes in the nervous system, including differentiation, specification, polarity, plasticity and axon growth. In addition, GSK-3β is one of the most important molecules downstream of PKB. In the present study, we report on the role of GSK-3β signaling on Nogo-66-treated mouse neuroblastoma N2a cells. Nogo-66 reduced the phosphorylation of GSK-3β at Ser9 in N2a cells. In contrast, pretreatment with SB216763, a specific inhibitor of GSK-3β, resulted in an amelioration of neurite outgrowth by Nogo-66, compared with the Nogo-66 alone group (P < 0.05). Moreover, we performed RNA interference experiments to knock down GSK-3β expression levels in N2a cells via transient transfection of shRNA plasmids. The inhibition of neurite outgrowth by Nogo-66 was subdued in shRNA cells, compared to the non-RNAi cells (P < 0.05). Taken together, these data suggest that GSK-3β is involved in the inhibition by Nogo-66 of neurite outgrowth in N2a cells.

► Here we report the role of GSK-3β on neurite outgrowth of Nogo-66-treated N2a cells. ► Nogo-66 reduced the phosphorylation level of GSK-3β at Ser9 in N2a cells. ► Pretreatment with SB216763 resulted in amelioration of neurite outgrowth inhibition. ► Inhibition of neurite outgrowth by Nogo-66 was subdued in shRNA N2a cells. ► GSK-3β is involved in the inhibition of neurite outgrowth by Nogo-66 in N2a cells.